Advertisement
Screener

OMEROS CORP (OMER) Net Margin

OMEROS CORP (OMER) Net Margin

  • 2026-06-30: Net Margin 46.38%.
  • 2026-03-31: Net Margin 566.66%.
  • 2021-09-30: Net Margin -75.67%.
  • 2021-06-30: Net Margin -99.20%.

Complete source-backed net margin history.

Available history
2009-12-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-3046.38%
2026-03-31566.66%
2021-09-30-75.67%
2021-06-30-99.20%
2021-03-31-166.61%
2020-12-31-350.57%
2020-09-30-147.29%
2020-06-30-246.08%
2020-03-31-123.34%
2019-12-31-87.46%
2019-09-30-55.14%
2019-06-30-54.02%
2019-03-31-111.78%
2018-12-31-106.89%
2018-09-30-856.60%
2018-06-30-2036.07%
2018-03-31-1892.57%
2017-12-31-120.29%
2017-09-30-34.55%
2017-06-30-83.72%
2017-03-31-123.11%
2016-12-31-152.13%
2016-09-30-123.68%
2016-06-30-126.07%
2016-03-31-276.84%
2015-12-31-297.02%
2015-09-30-611.26%
2015-06-30-523.38%
2015-03-31-4811.60%
2014-12-31-11507.22%
2014-09-30-8564.02%
2014-06-30-39980.00%
2014-03-31-16642.00%
2013-12-31-1091.72%
2013-09-30-7076.53%
2013-06-30-9708.57%
2013-03-31-957.90%
2012-12-31-488.57%
2012-09-30-936.91%
2012-06-30-559.57%
2012-03-31-594.59%
2011-12-31-892.48%
2011-09-30-659.78%
2011-06-30-458.10%
2011-03-31-528.01%
2010-12-31-740.88%
2010-09-30-2974.41%
2010-06-30-1570.22%

Annual Net Margin

DateNet Margin
2020-12-31-187.04%
2019-12-31-75.57%
2018-12-31-424.39%
2017-12-31-82.50%
2016-12-31-160.38%
2015-12-31-555.90%
2014-12-31-13668.46%
2013-12-31-2487.25%
2012-12-31-638.39%
2011-12-31-630.99%
2010-12-31-1389.60%
2009-12-31-1460.46%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Ultragenyx Pharmaceutical Inc. (RARE)United States$1.456B-5.62
ArriVent BioPharma, Inc. (AVBP)United States$1.485B-10.25
Innoviva, Inc. (INVA)United States$1.493B4.62
Oric Pharmaceuticals, Inc. (ORIC)United States$1.367B-8.00
ANAPTYSBIO, INC (ANAB)United States$1.546B-60.20
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
Kardigan, Inc. (KARD)United States$1.346B
Tyra Biosciences, Inc. (TYRA)United States$1.337B-12.83
Bicara Therapeutics Inc. (BCAX)United States$1.309B-10.55
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82